VCM
EVH icon

Voce Capital Management’s Evolent Health EVH Stock Holding History

Voce Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,291
Closed -$1.65M – 10
2019
Q3 		$1.65M Buy
+2,291
New +$16.4K 0.88% 12

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Voce Capital Management's EVH Position: Q2 2023 in Review

Voce Capital Management reduced its Evolent Health (EVH) stake by 9.6% in Q2 2023, selling an estimated $1.11M and leaving 323,694 shares worth $9.81M. The position accounts for 16.97% of the portfolio, ranked #3.

Voce Capital Management first reported a position in EVH in Q2 2019 and has held it in 17 quarters since. The position peaked at $12.1M in Q1 2022. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

  • Voce Capital Management held 323,694 shares of Evolent Health worth $9.81M as of Q2 2023.
  • Voce Capital Management sold 34,357 Evolent Health shares in Q2 2023, an estimated $1.11M.
  • Evolent Health made up 16.97% of Voce Capital Management's portfolio in Q2 2023, its #3 holding.
  • Voce Capital Management first reported a position in Evolent Health in Q2 2019 and has held it in 17 quarters since.
  • Voce Capital Management's Evolent Health position peaked at $12.1M in Q1 2022.
  • 217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Voce Capital Management's 13F filing for Q2 2023, filed 31 Jul 2023.